Acute felon as a complication of systemic paclitaxel therapy: case report and review of the literature.
Breast cancer now affects 1 in 8 American women and the taxane agent paclitaxel (Taxol Bristol-Myers Squibb) is a major tool in the treatment of many such patients. Hand surgeons are therefore likely to encounter upper extremity complications related to the use of taxane therapy. We present an unusual case of a felon developing in a breast cancer patient on paclitaxel therapy with no antecedent history of trauma. Whereas onycholysis and subungual hemorrhage are reported complications of taxane therapy (Fig. 1), an acute felon with or without associated paronychia is an unusual and more aggressive manifestation of this drug-related nail dystrophy.
Hijjawi
John B
JB
Department of Plastic Surgery, Medical College of Wisconsin, 8700 Watertown Plank Road, Milwaukee, WI, 53226, USA. johnhijjawi@hotmail.com
Dennison
David G
DG
Cancer. 2000 May 15;88(10):2367-71
10820360
Rev Interam Radiol. 1976 Jul;1(1):9-13
1027061
Oncology (Williston Park). 2006 Aug;20(9):983-90; discussion 991-2, 997-8
16986346
Australas J Dermatol. 2002 Nov;43(4):293-6
12423438
Expert Opin Investig Drugs. 2006 Nov;15(11):1411-25
17040200
Ann Oncol. 2003 Feb;14(2):333-7
12562663
Ann Oncol. 1998 Oct;9(10):1139-40
9834830
J Hand Surg Am. 2000 Jan;25(1):173-5
10642489